3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
3
Leukemia, Myeloid, Acute
3
Glioblastoma
3
Brain Neoplasms
3
Glioma
2
Thyroid Neoplasms
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neurologic Manifestations
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Lymphoma
1
Leukemia
1
Head and Neck Neoplasms
1
HTLV-I Infections
1
Gliosarcoma
1
Diffuse Intrinsic Pontine Glioma
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
Doxorubicin
33
Ifosfamide
23
Gemcitabine
19
pazopanib
18
Cyclophosphamide
16
Radiotherapy
15
pembrolizumab
13
Filgrastim
12
Docetaxel
12
Bevacizumab
10
Vincristine
9
Sirolimus
9
Irinotecan
9
Etoposide
9
olaratumab
7
eribulin
7
Sorafenib
7
Radiation
7
temsirolimus
6
Temozolomide
6
Mesna
6
Magnetic Resonance Spectroscopy
6
Cisplatin
6
tazemetostat
5
cixutumumab
5
Trabectedin
5
Radiosurgery
5
Nivolumab
5
Ipilimumab
5
Granulocyte Colony-Stimulating Factor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma
×
Valproic Acid
×
Clear all
No trials found.